ArticlePharmacoEconomics2024

Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate Cancer in the United States.

Christopher W Yee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.